Craig Schneider, MD
Radiation Oncology · Indianapolis, INNPI 1033616289
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations.
Across 76 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$207
- Novartis$186
- Bayer$148
- Acrotech Biopharma Inc.$140
- Johnson & Johnson$136
- Novocure Inc.$129
- plus $769 from 25 others
What the payments were for
- Food & beverage$1,716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $207 |
| Novartis | 10 | $186 |
| Bayer | 6 | $148 |
| Acrotech Biopharma Inc. | 4 | $140 |
| Johnson & Johnson | 5 | $136 |
| Novocure Inc. | 2 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Exelixis Inc. | 3 | $50 |
| Incyte Corporation | 2 | $46 |
| Servier Pharmaceuticals LLC | 2 | $44 |
| Astellas Pharma US Inc | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Progenics Pharmaceuticals, Inc. | 2 | $39 |
| Merck | 2 | $38 |
| Genentech USA, Inc. | 2 | $36 |
| Seagen Inc. | 2 | $35 |
| Geron Corporation | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 2 | $27 |
| Pfizer | 1 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $21 |
| Taiho Oncology, Inc. | 1 | $19 |
| Coherus Oncology, Inc. | 1 | $19 |
| GSK | 1 | $18 |
| CTI Biopharma Corp. | 1 | $17 |
| Foundation Medicine, Inc. | 1 | $16 |
| Beigene USA, Inc. | 1 | $16 |
| Syndax Pharmaceuticals, Inc. | 1 | $15 |
| Caris MPI, Inc. | 1 | $14 |
| Beone Medicines USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune Gio$113
How this compares
$1,716 in reported general payments places this provider in the 75th percentile of 116 radiation oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 45 | $720 |
| Ondansetron Hcl | 12 | $352 |
| Dexamethasone | 20 | $270 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $269 |
| Tamsulosin Hcl | 29 | $109 |
| Methylprednisolone | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Indianapolis
- Michael EatonIndianapolis$11K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Peter GarrettIndianapolis$5K
- Garrett JensenIndianapolis$4K
- Alexander YehIndianapolis$3K
- Erin McCammackIndianapolis$2K
- Zachary OaksIndianapolis$2K
- David KimIndianapolis$2K
- Darrel RossIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.